title: Assessment of viral replication in eggs and HA protein yield of pre-pandemic H5N1 candidate vaccine viruses.
abstract: H5N1 infection and the potential for spread from human to human continue to pose a severe public health concern. Since vaccination remains the most effective way to prevent a potential H5N1 pandemic, the World Health Organization (WHO) Collaborating Centers (CCs) and Essential Regulatory Laboratories (ERLs) engineered and developed a panel of H5N1 pre-pandemic vaccine viruses for pandemic vaccine preparedness as well as production of antigen potency testing reagents (reference antigen and reference anti-serum) for vaccine standardization. To develop a strategy utilizing a number of biochemical methods for the characterization of the viral growth properties and protein yield in eggs, we have selected eight H5N1 pre-pandemic viruses and determined the viral Egg Infectious Dose 50 (EID50), total protein yield, hemagglutinin (HA) to nucleoprotein (NP) ratios (HA:NP), and HA1 content of each virus. Our results showed that all the tested H5N1 vaccine viruses grew to high titers in eggs. The total viral protein yield varies within a narrow range, whereas there were greater differences in the HA:NP protein ratios among the eight viruses. The RP-HPLC based HA1 content analysis demonstrated that the viruses A/Anhui/1/2010, A/Hubei/1/2005, and A/goose/Guiyang/337/2006 contained higher HA contents than other five viruses including A/Vietnam/1203/2003. Our approach for analyzing virus growth and protein yield will allow us identify optimal vaccine virus in a timely manner. In addition, we successfully purified the HA proteins of H5N1 vaccine viruses by optimizing bromelain cleavage conditions. Our studies on the HA protein purification may improve the quality control of the production of influenza vaccine test reagent.
authors.affiliation: Laboratory of Respiratory Viral Diseases, Division of Viral Products, Office of Vaccine Research and Review, United States Food and Drug Administration, 8800 Rockville Pike, Bethesda, MD 20892, United States.
authors.forename: Xianghong
authors.initials: X
authors.lastname: Jing
authors.forename: Jackeline
authors.initials: J
authors.lastname: Soto
authors.forename: Yamei
authors.initials: Y
authors.lastname: Gao
authors.forename: Kathryn
authors.initials: K
authors.lastname: Phy
authors.forename: Zhiping
authors.initials: Z
authors.lastname: Ye
mesh_terms: D000818:Animals; D001963:Bromelains / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004531:Eggs / Q000821:virology*; D004591:Electrophoresis, Polyacrylamide Gel; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000302:isolation & purification* / Q000378:metabolism*; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism*; D007252:Influenza Vaccines
chemical_list: D019267:Hemagglutinin Glycoproteins, Influenza Virus; D007252:Influenza Vaccines; D001963:Bromelains
keywords: HA bromelain cleavage; HA purification; Influenza H5N1 virus protein yield; Influenza pandemic preparedness